您的位置: 首页 > 农业专利 > 详情页

PROTEINE DE FUSION PD1-41BBL ET SES METHODES D'UTILISATION
专利权人:
KAHR MEDICAL LTD.
发明人:
TYKOCINSKI, MARK L.,SHANI, NOAM,GOZLAN, YOSI,DRANITZKI ELHALEL, MICHAL,BREMER, EDWIN,KAMINSKY, IDO
申请号:
CA3047707
公开号:
CA3047707A1
申请日:
2018.01.04
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
PD1-41BBL fusion proteins are provided. Accordingly, there is provided a PD1-41BBL fusion protein comprising a single amino acid linker between the PD1 and the 41BBL. Also there is provided a PD1-41BBL fusion protein, wherein the PD1 amino acid is 123-166 amino acids in length and/or wherein the PD1 amino acid sequence comprises SEQ ID NO: 2 and/or wherein the fusion protein is in a form of at least a homo-trimer. Also provided are polynucleotides and nucleic acid constructs encoding the PD1-41BBL fusion protein, host-cells expressing the PD1-41BBL fusion protein and methods of use thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充